| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.67e-10 | 11 | 226 | 6 | GO:0004523 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P WRN ATP10A MCM9 MACF1 HSP90AB2P | 3.35e-08 | 441 | 226 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90B1 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM ACSL1 DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P MYH7B WRN ATP10A MCM9 ERCC6L2 MACF1 HSP90AB2P TOP2B | 3.44e-08 | 614 | 226 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | HSP90B1 CLPX HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P HSP90AB2P | 2.94e-07 | 40 | 226 | 7 | GO:0140662 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ERVK-7 ERVK-10 BLM ERVK-11 NIPBL DNMT1 RBBP8 WRN N4BP2 MCM9 ERVK-8 ERCC6L2 EXO1 TOP2B | 3.27e-07 | 262 | 226 | 15 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.27e-07 | 14 | 226 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.11e-06 | 79 | 226 | 8 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.12e-06 | 21 | 226 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.41e-06 | 37 | 226 | 6 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity | ERVK-6 ERVK-7 ERVK-10 SLFN14 ERVK-11 RBBP8 NOB1 N4BP2 ERVK-8 EXO1 | 3.47e-06 | 136 | 226 | 10 | GO:0004519 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.26e-05 | 46 | 226 | 6 | GO:0016893 | |
| GeneOntologyMolecularFunction | protein folding chaperone | HSP90B1 CLPX HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P HSP90AB2P | 1.87e-05 | 73 | 226 | 7 | GO:0044183 |
| GeneOntologyMolecularFunction | enzyme activator activity | ARHGAP32 MYO9B PSME1 CLPX DDOST TAOK2 ACSL1 DLC1 SRGAP3 RIN2 PLCB1 ELMOD3 DMWD ITSN1 RICTOR RAB3GAP1 ARAP3 ARHGAP12 GNB5 CTSV PCOLCE | 1.93e-05 | 656 | 226 | 21 | GO:0008047 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 CMTR1 DDX42 ERVK-7 ERVK-10 SLFN14 BLM ERVK-11 NIPBL DNMT1 RBBP8 NOB1 WRN N4BP2 MCM9 ERVK-8 ERCC6L2 EXO1 CMTR2 TOP2B | 4.79e-05 | 645 | 226 | 20 | GO:0140640 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 6.58e-05 | 38 | 226 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 6.71e-05 | 20 | 226 | 4 | GO:0008525 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 ERVK-7 ERVK-10 SLFN14 ERVK-11 RBBP8 NOB1 WRN N4BP2 ERVK-8 EXO1 | 6.82e-05 | 231 | 226 | 11 | GO:0004518 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 DOCK11 MYO9B SH3BP4 DLC1 SRGAP3 RIN2 EIF2B4 PLCB1 ELMOD3 ITSN1 PSD3 KRIT1 RAB3GAP1 ARAP3 ARHGAP12 GNB5 | 6.99e-05 | 507 | 226 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 DOCK11 MYO9B SH3BP4 DLC1 SRGAP3 RIN2 EIF2B4 PLCB1 ELMOD3 ITSN1 PSD3 KRIT1 RAB3GAP1 ARAP3 ARHGAP12 GNB5 | 6.99e-05 | 507 | 226 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSP90B1 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P WRN ATP10A MCM9 GNB5 MACF1 HSP90AB2P | 7.38e-05 | 775 | 226 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | disordered domain specific binding | 7.48e-05 | 39 | 226 | 5 | GO:0097718 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 7.68e-05 | 8 | 226 | 3 | GO:0090554 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSP90B1 PLPP5 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P WRN ATP10A MCM9 GNB5 MACF1 HSP90AB2P | 8.52e-05 | 839 | 226 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSP90B1 PLPP5 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P WRN ATP10A MCM9 GNB5 MACF1 HSP90AB2P | 8.67e-05 | 840 | 226 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSP90B1 PLPP5 ABCA13 MYO9B KIF1B DDX42 AK9 CLPX ABCA10 ABCB1 ABCB4 BLM DNAH6 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P WRN ATP10A MCM9 GNB5 MACF1 HSP90AB2P | 8.67e-05 | 840 | 226 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | unfolded protein binding | HSP90B1 NACA CLPX HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P HSP90AB2P | 9.50e-05 | 126 | 226 | 8 | GO:0051082 |
| GeneOntologyMolecularFunction | CTP binding | 1.28e-04 | 2 | 226 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | mRNA (nucleoside-2'-O-)-methyltransferase activity | 1.28e-04 | 2 | 226 | 2 | GO:0004483 | |
| GeneOntologyMolecularFunction | forked DNA-dependent helicase activity | 1.28e-04 | 2 | 226 | 2 | GO:0061749 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGAP32 DOCK11 MYO9B PSME1 CLPX DDOST SH3BP4 TAOK2 ACSL1 DLC1 SRGAP3 RIN2 EIF2B4 PLCB1 ELMOD3 DMWD HSP90AA1 HSP90AB1 ITSN1 PSD3 RICTOR PABIR2 KRIT1 RAB3GAP1 ARAP3 ELFN1 ARHGAP12 GNB5 AKAP11 CTSV PTTG2 PCOLCE | 1.43e-04 | 1418 | 226 | 32 | GO:0030234 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.62e-04 | 136 | 226 | 8 | GO:0004540 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 MYO9B DLC1 SRGAP3 RIN2 PLCB1 ELMOD3 RAB3GAP1 ARAP3 ARHGAP12 GNB5 | 3.54e-04 | 279 | 226 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | 8-hydroxy-2'-deoxyguanosine DNA binding | 3.80e-04 | 3 | 226 | 2 | GO:1905773 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 3.80e-04 | 3 | 226 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 3.80e-04 | 3 | 226 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | telomeric G-quadruplex DNA binding | 3.80e-04 | 3 | 226 | 2 | GO:0061849 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP6 MYO9B KIF1B ACTN3 NEB DYSF TAOK2 PPARGC1A DLC1 AP1G1 AIF1 HSP90AA1 HSP90AB1 CACNA1D FLNC MYH7B CAPN2 CEP290 TOGARAM2 ACTR3B SLC4A1 KRIT1 P4HB CEP135 MACF1 | 7.16e-04 | 1099 | 226 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | floppase activity | 7.19e-04 | 16 | 226 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | UTP binding | 7.54e-04 | 4 | 226 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 7.54e-04 | 4 | 226 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | Y-form DNA binding | 7.54e-04 | 4 | 226 | 2 | GO:0000403 | |
| GeneOntologyMolecularFunction | telomeric D-loop binding | 7.54e-04 | 4 | 226 | 2 | GO:0061821 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.87e-04 | 37 | 226 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 8.72e-04 | 38 | 226 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 1.18e-03 | 70 | 226 | 5 | GO:0016504 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 1.25e-03 | 5 | 226 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 1.25e-03 | 5 | 226 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.41e-03 | 20 | 226 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.45e-03 | 147 | 226 | 7 | GO:0042826 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 1.52e-03 | 74 | 226 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | sialyltransferase activity | 1.64e-03 | 21 | 226 | 3 | GO:0008373 | |
| GeneOntologyMolecularFunction | molecular function activator activity | ARHGAP32 IL16 MYO9B PDYN PSME1 CLPX DDOST TAOK2 BLM ACSL1 DLC1 SRGAP3 RIN2 PLCB1 ELMOD3 DMWD ITSN1 RICTOR DLL1 RAB3GAP1 ARAP3 ARHGAP12 GNB5 CTSV PTTG2 PCOLCE | 1.67e-03 | 1233 | 226 | 26 | GO:0140677 |
| GeneOntologyMolecularFunction | ubiquitin ligase complex scaffold activity | 1.86e-03 | 6 | 226 | 2 | GO:0160072 | |
| GeneOntologyMolecularFunction | D-loop DNA binding | 1.86e-03 | 6 | 226 | 2 | GO:0062037 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.86e-03 | 6 | 226 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity | 1.86e-03 | 6 | 226 | 2 | GO:0001665 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.86e-03 | 6 | 226 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.14e-03 | 23 | 226 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.27e-03 | 49 | 226 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 2.58e-03 | 7 | 226 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.63e-03 | 51 | 226 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 2.74e-03 | 25 | 226 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | TPR domain binding | 3.41e-03 | 8 | 226 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 3.41e-03 | 8 | 226 | 2 | GO:0000405 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.80e-03 | 28 | 226 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.12e-03 | 93 | 226 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 4.36e-03 | 9 | 226 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 4.36e-03 | 9 | 226 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 CYP1A1 AKAP8 MYO9B ERVK-7 ERVK-10 NR4A1 CLPX F8 MEP1A BLM SCAPER ERVK-11 DNMT1 CA7 MIOX WRN BAZ1B DPP3 PHF5A ZZZ3 CYP2R1 ERVK-8 ZMYM6 | 4.36e-03 | 1189 | 226 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | actin filament binding | 4.43e-03 | 227 | 226 | 8 | GO:0051015 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.77e-07 | 13 | 225 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 8.43e-07 | 48 | 225 | 7 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 ERVK-7 ERVK-10 BLM ERVK-11 RBBP8 WRN PRIM2 MCM9 ERVK-8 EXO1 | 4.30e-06 | 178 | 225 | 11 | GO:0006261 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.44e-05 | 83 | 225 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | positive regulation of skeletal muscle tissue growth | 4.34e-05 | 7 | 225 | 3 | GO:0048633 | |
| GeneOntologyCellularComponent | aryl hydrocarbon receptor complex | 6.62e-05 | 8 | 225 | 3 | GO:0034751 | |
| GeneOntologyCellularComponent | nuclear body | TPP2 MAGEA6 IL16 RPN2 DDX42 ANKS1B BLM PPARGC1A RBM19 SCAPER PLCB1 HCFC2 HEATR5B NUDT21 AFF3 WRN ZC3H18 SYF2 PHF5A ARNT EXO1 ZNF350 USPL1 | 1.21e-04 | 903 | 225 | 23 | GO:0016604 |
| GeneOntologyCellularComponent | dendritic growth cone | 2.52e-04 | 12 | 225 | 3 | GO:0044294 | |
| Domain | Heat_shock_protein_90_CS | 1.59e-06 | 3 | 219 | 3 | IPR019805 | |
| Domain | - | 2.84e-06 | 20 | 219 | 5 | 3.30.565.10 | |
| Domain | HATPase_C | 3.70e-06 | 21 | 219 | 5 | IPR003594 | |
| Domain | Hsp90_fam | 6.31e-06 | 4 | 219 | 3 | IPR001404 | |
| Domain | Hsp90_N | 6.31e-06 | 4 | 219 | 3 | IPR020575 | |
| Domain | HSP90 | 6.31e-06 | 4 | 219 | 3 | PF00183 | |
| Domain | HSP90 | 6.31e-06 | 4 | 219 | 3 | PS00298 | |
| Domain | HATPase_c | 4.95e-05 | 18 | 219 | 4 | SM00387 | |
| Domain | HATPase_c | 6.21e-05 | 19 | 219 | 4 | PF02518 | |
| Domain | Rho_GTPase_activation_prot | 7.86e-05 | 88 | 219 | 7 | IPR008936 | |
| Domain | RhoGAP | 8.63e-05 | 62 | 219 | 6 | SM00324 | |
| Domain | RhoGAP | 9.45e-05 | 63 | 219 | 6 | PF00620 | |
| Domain | RhoGAP_dom | 1.03e-04 | 64 | 219 | 6 | IPR000198 | |
| Domain | - | 1.03e-04 | 64 | 219 | 6 | 1.10.555.10 | |
| Domain | RHOGAP | 1.03e-04 | 64 | 219 | 6 | PS50238 | |
| Domain | RQC | 1.37e-04 | 2 | 219 | 2 | SM00956 | |
| Domain | AAA+_ATPase | 3.02e-04 | 144 | 219 | 8 | IPR003593 | |
| Domain | AAA | 3.02e-04 | 144 | 219 | 8 | SM00382 | |
| Domain | HRDC | 4.07e-04 | 3 | 219 | 2 | PS50967 | |
| Domain | - | 4.07e-04 | 3 | 219 | 2 | 1.10.150.80 | |
| Domain | HRDC | 4.07e-04 | 3 | 219 | 2 | SM00341 | |
| Domain | RQC_domain | 4.07e-04 | 3 | 219 | 2 | IPR018982 | |
| Domain | RQC | 4.07e-04 | 3 | 219 | 2 | PF09382 | |
| Domain | HRDC | 4.07e-04 | 3 | 219 | 2 | PF00570 | |
| Domain | Ribosomal_S5_D2-typ_fold | 6.47e-04 | 34 | 219 | 4 | IPR020568 | |
| Domain | RecQ_Zn_bind | 8.09e-04 | 4 | 219 | 2 | PF16124 | |
| Domain | CABIT | 8.09e-04 | 4 | 219 | 2 | PF12736 | |
| Domain | HRDC_dom | 8.09e-04 | 4 | 219 | 2 | IPR002121 | |
| Domain | RecQ_Zn-bd | 8.09e-04 | 4 | 219 | 2 | IPR032284 | |
| Domain | CABIT_dom | 8.09e-04 | 4 | 219 | 2 | IPR025946 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 1.33e-05 | 26 | 171 | 5 | M27558 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 3.41e-05 | 6 | 171 | 3 | M27793 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 5.92e-05 | 7 | 171 | 3 | MM15528 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 5.99e-05 | 35 | 171 | 5 | M249 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 MYO9B NACA CLPX DDOST BLM ACSL1 AP1G1 RBM19 EIF2B4 NIPBL HSP90AA1 DNMT1 HSP90AB1 CUL1 FLNC DNAJC13 CAPN2 NOB1 BAZ1B RICTOR WDR5 RAB3GAP1 GTF2I ARAP3 P4HB NANS PRIM2 MACF1 TANC1 HSP90AB2P TOP2B | 3.35e-10 | 1353 | 227 | 32 | 29467282 |
| Pubmed | TDRD15 AKAP8 VPS13C KIF1B C2CD4C RYR2 SH3BP4 BLM RBM19 EIF2B4 HCFC2 ADGRL2 HSP90AA1 DNMT1 DNAJC13 WDR7 WRN MUC16 RICTOR GTF2I IGF2R TENM3 ANO6 PCCA | 3.80e-10 | 777 | 227 | 24 | 35844135 | |
| Pubmed | HSP90B1 RPN2 DDX42 ANKS1B ACTN3 CLPX NEB LYST RYR2 CHUK ABCB1 ABCB4 STXBP2 SACS DLG2 DMWD DNAH6 NIPBL HSP90AA1 HSP90AB1 PLXNA3 FLNC RBBP8 MYH7B ITSN1 PHF5A P4HB N4BP2 ARHGAP12 MACF1 ZNF350 USPL1 TOP2B | 3.97e-10 | 1442 | 227 | 33 | 35575683 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 5.49e-10 | 16 | 227 | 6 | 16269234 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 HIVEP2 AKAP8 PDGFRA DOCK11 KIF1B LYST SH3BP4 DLC1 NFATC3 MEX3B WDR62 DNMT1 FOXO1 MAPKAP1 KIAA0930 PSD3 RICTOR PABIR2 N4BP2 EXO1 MACF1 AKAP11 CEP152 TANC1 | 5.71e-10 | 861 | 227 | 25 | 36931259 |
| Pubmed | HSP90B1 AKAP8 RPN2 DDX42 CLPX DDOST SH3BP4 BLM SACS EIF2B4 WRAP73 ADGRL2 SUCO WDR62 DNMT1 MAPKAP1 DNAJC13 HSDL2 ITSN1 RTN4 PSD3 BAZ1B RICTOR RAB3GAP1 IGF2R P4HB ANO6 N4BP2 MACF1 AKAP11 TANC1 TOP2B | 3.35e-09 | 1487 | 227 | 32 | 33957083 | |
| Pubmed | TPP2 ARHGAP32 HSP90B1 IL16 MAP6 KIF1B ANKS1B ACTN3 AP1G1 SACS SRGAP3 SCAPER DLG2 DNAH6 HSP90AA1 HSP90AB1 CUL3 FLNC DNAJC13 WDR7 NUDT21 ITSN1 RTN4 PSD3 ACTR3B SLC4A1 P4HB GNB5 PDE4DIP MACF1 TANC1 | 5.18e-09 | 1431 | 227 | 31 | 37142655 | |
| Pubmed | TPP2 ARHGAP32 HSP90B1 RPN2 PSME1 CLPX C2CD4C DDOST BLM ADGRL2 DMWD HSP90AA1 DNMT1 HSP90AB1 ZNF703 DNAJC13 HSDL2 CEP290 PSD3 RICTOR PABIR2 IGF2R P4HB PRIM2 CEP135 TANC1 | 6.82e-09 | 1049 | 227 | 26 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 VPS13C KIF1B PSME1 STXBP2 NFATC3 WRAP73 WDR62 HSP90AA1 HSP90AB1 CUL3 ITSN1 CEP290 NOB1 TSFM IGF2R NANS N4BP2 ARHGAP12 CEP135 CEP152 TANC1 PCCA | 1.16e-08 | 853 | 227 | 23 | 28718761 |
| Pubmed | ARHGAP32 HSP90B1 MAP6 NACA ANKS1B RYR2 TAOK2 SRGAP3 PLCB1 DLG2 HSP90AA1 HSP90AB1 MAPKAP1 RTN4 CAPN2 PSD3 RICTOR WDR5 ACTR3B RAB3GAP1 P4HB ELFN1 GNB5 PDE4DIP MACF1 PCCA | 3.56e-08 | 1139 | 227 | 26 | 36417873 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPP2 HSP90B1 RPN2 NACA PSME1 CLPX DDOST AP1G1 RBM19 EIF2B4 NIPBL HSP90AA1 DNMT1 HSP90AB1 HSDL2 NUDT21 CAPN2 NOB1 WDR5 ZC3H18 CPS1 GTF2I SLC16A3 P4HB PRIM2 MACF1 HSP90AB2P CTSV TOP2B | 5.60e-08 | 1415 | 227 | 29 | 28515276 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9B KIF1B BLM NFATC3 ARID5B FOXO1 CUL1 ZNF703 RBBP8 ITSN1 BAZ1B ZC3H18 ARNT ZZZ3 N4BP2 MACF1 TANC1 ZMYM6 | 7.53e-08 | 588 | 227 | 18 | 38580884 |
| Pubmed | TPP2 ARHGAP32 AKAP8 MAP6 DOCK11 ANKS1B TAOK2 NFATC3 SRGAP3 PLCB1 DLG2 NIPBL HSP90AA1 DNMT1 HSP90AB1 CUL3 DNAJC13 WDR7 ITSN1 IGF2R N4BP2 PDE4DIP MACF1 | 1.04e-07 | 963 | 227 | 23 | 28671696 | |
| Pubmed | 2.74e-07 | 3 | 227 | 3 | 28158196 | ||
| Pubmed | 2.74e-07 | 3 | 227 | 3 | 33145341 | ||
| Pubmed | 2.74e-07 | 3 | 227 | 3 | 24511009 | ||
| Pubmed | 2.74e-07 | 3 | 227 | 3 | 24366168 | ||
| Pubmed | Delineation of WRN helicase function with EXO1 in the replicational stress response. | 2.74e-07 | 3 | 227 | 3 | 20447876 | |
| Pubmed | HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. | 2.74e-07 | 3 | 227 | 3 | 29768689 | |
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 3.12e-07 | 42 | 227 | 6 | 29348145 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | AKAP8 RPN2 DDX42 NR4A1 DDOST BLM ARID5B HCFC2 NIPBL DNMT1 CUL1 NUDT21 CEP290 WRN EI24 BAZ1B WDR5 ZC3H18 SYF2 PHF5A ARNT GTF2I ZZZ3 EXO1 PCCA TOP2B | 4.20e-07 | 1294 | 227 | 26 | 30804502 |
| Pubmed | ARHGAP32 HSP90B1 HIVEP2 NEB SH3BP4 ZNF600 PLCB1 HSP90AA1 GAREM1 HSP90AB1 FLNC ITSN1 CEP290 N4BP2 MACF1 | 8.54e-07 | 486 | 227 | 15 | 20936779 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPP2 HSP90B1 RPN2 NACA DDX42 PSME1 SCAPER DNAH6 NIPBL HSP90AA1 DNMT1 HSP90AA2P HSP90AB1 HSP90AB3P CUL1 FLNC PHF5A GTF2I MACF1 HSP90AB2P | 8.76e-07 | 847 | 227 | 20 | 35235311 |
| Pubmed | ARHGAP32 CMTR1 SACS SCAPER MEX3B KIAA0930 CEP290 RICTOR ATP10A RAB3GAP1 N4BP2 CEP135 MACF1 CEP152 UNC80 | 1.02e-06 | 493 | 227 | 15 | 15368895 | |
| Pubmed | 1.09e-06 | 4 | 227 | 3 | 23589305 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.09e-06 | 4 | 227 | 3 | 10469592 | |
| Pubmed | 1.09e-06 | 4 | 227 | 3 | 2069718 | ||
| Pubmed | 1.09e-06 | 4 | 227 | 3 | 34196494 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RNF223 HIVEP2 MAN2A2 MYO9B KDM6B DYSF LYST SH3BP4 TAOK2 RBM19 DMWD GAREM1 PLXNA3 FLNC KIAA0930 RTTN NOB1 CFAP43 DLL1 IGF2R ARAP3 TANC1 MAPKBP1 | 1.13e-06 | 1105 | 227 | 23 | 35748872 |
| Pubmed | 1.25e-06 | 83 | 227 | 7 | 35124280 | ||
| Pubmed | NACA HSP90AA2P HSP90AB3P MAPKAP1 FLNC RICTOR GTF2I IGF2R NANS HSP90AB2P | 1.69e-06 | 215 | 227 | 10 | 35973513 | |
| Pubmed | HSP90B1 RPN2 KIF1B NACA EIF2B4 WDR62 HSP90AA1 HSP90AB1 CUL3 CUL1 FLNC HSDL2 NUDT21 PHF5A GTF2H3 GTF2I IGF2R P4HB TANC1 | 1.80e-06 | 809 | 227 | 19 | 32129710 | |
| Pubmed | Germline genomic variants associated with childhood acute lymphoblastic leukemia. | 2.28e-06 | 15 | 227 | 4 | 19684603 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACTN3 DYSF ABCB1 ABCB4 FCGBP STXBP2 ST3GAL6 FCGR3B HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P GPLD1 ACTR3B ORM2 IGF2R NANS ANO6 FOLH1B HSP90AB2P PGM2 PCOLCE | 2.38e-06 | 1070 | 227 | 22 | 23533145 |
| Pubmed | Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. | 2.72e-06 | 5 | 227 | 3 | 19586661 | |
| Pubmed | 2.72e-06 | 5 | 227 | 3 | 18566586 | ||
| Pubmed | 2.72e-06 | 5 | 227 | 3 | 17707923 | ||
| Pubmed | 2.72e-06 | 5 | 227 | 3 | 9083006 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ARHGAP32 MAP6 ANKS1B SACS SRGAP3 PIP5KL1 DLG2 CUL3 WDR7 MACF1 AKAP11 | 2.73e-06 | 281 | 227 | 11 | 28706196 |
| Pubmed | HSP90B1 AKAP8 PDGFRA RPN2 MYO9B DDX42 DDOST ACSL1 AP1G1 RBM19 SCP2 HEATR5B HSP90AA1 HSP90AB1 CUL3 DNAJC13 HSDL2 CEP290 EI24 GTF2I IGF2R ABHD17B ANO6 | 2.85e-06 | 1168 | 227 | 23 | 19946888 | |
| Pubmed | HSP90B1 NACA PSME1 HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P CUL1 NUDT21 RTN4 NOB1 SYF2 MACF1 HSP90AB2P PCCA | 2.98e-06 | 538 | 227 | 15 | 28524877 | |
| Pubmed | 3.02e-06 | 16 | 227 | 4 | 20301772 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HSP90B1 HIVEP2 RPN2 CLPX DDOST WRAP73 DMWD DNMT1 CUL3 CUL1 FLNC KIAA0930 WRN ZC3H18 DPP3 PABIR2 GTF2I IGF2R PRIM2 USPL1 ZMYM6 | 3.18e-06 | 1005 | 227 | 21 | 19615732 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AKAP8 KIF1B BLM DMWD NIPBL WDR62 DNMT1 HSP90AB1 CUL3 DNAJC13 RBBP8 ITSN1 BAZ1B RICTOR ZC3H18 GTF2I EXO1 TOP2B | 3.88e-06 | 774 | 227 | 18 | 15302935 |
| Pubmed | 3.96e-06 | 64 | 227 | 6 | 26511642 | ||
| Pubmed | 5.03e-06 | 18 | 227 | 4 | 34171383 | ||
| Pubmed | 5.41e-06 | 6 | 227 | 3 | 17050673 | ||
| Pubmed | RPN2 NACA CLPX DDOST SH3BP4 AP1G1 DNMT1 CUL3 MAPKAP1 RTN4 EI24 RICTOR ARNT ARAP3 TANC1 CMTR2 | 6.72e-06 | 650 | 227 | 16 | 38777146 | |
| Pubmed | ZNF486 PDGFRA CLPX DDOST ACSL1 ARID5B SCAPER ELMOD3 HCFC2 NIPBL MAPKAP1 HSD17B7 NUDT21 RICTOR ZC3H18 PHF5A RAB3GAP1 ARNT GTF2I P4HB MCM9 GNB5 CEP135 C9orf50 | 7.21e-06 | 1327 | 227 | 24 | 32694731 | |
| Pubmed | 7.62e-06 | 152 | 227 | 8 | 34299191 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CMTR1 DDX42 BLM HSP90AB1 FLNC RTN4 BAZ1B CPS1 ARNT GTF2I ZZZ3 PCCA TOP2B | 8.19e-06 | 444 | 227 | 13 | 34795231 |
| Pubmed | 9.42e-06 | 7 | 227 | 3 | 24618592 | ||
| Pubmed | 9.42e-06 | 7 | 227 | 3 | 24082123 | ||
| Pubmed | Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. | 9.42e-06 | 7 | 227 | 3 | 12471035 | |
| Pubmed | 9.42e-06 | 7 | 227 | 3 | 16288044 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSP90B1 AKAP8 MAP6 RPN2 DDX42 DDOST BLM SACS NIPBL HSP90AA1 HSP90AB1 FLNC DNAJC13 WDR7 NUDT21 EI24 ZC3H18 ZNF532 P4HB MACF1 TOP2B | 9.78e-06 | 1082 | 227 | 21 | 38697112 |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.07e-05 | 265 | 227 | 10 | 19240061 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | AKAP8 MYO9B NACA DDOST BLM EIF2B4 SCAPER DNMT1 CUL3 DNAJC13 WRN BAZ1B WDR5 MCM9 EXO1 MACF1 TOP2B | 1.18e-05 | 759 | 227 | 17 | 35915203 |
| Pubmed | 1.25e-05 | 46 | 227 | 5 | 31560077 | ||
| Pubmed | TDRD15 HSP90B1 RPN2 MYO9B NACA PSME1 CLPX NEB DDOST HSP90AA1 HSP90AB1 FLNC MUC16 ACTR3B PHF5A P4HB MACF1 HSP90AB2P | 1.25e-05 | 844 | 227 | 18 | 25963833 | |
| Pubmed | HSP90B1 HIVEP2 KIF1B ANKS1B PSME1 KDM6B CHUK SACS ARID5B DLG2 NIPBL HSP90AA1 DNMT1 HSP90AB1 ITSN1 CEP290 ACTR3B KRIT1 ZNF532 PDE4DIP MACF1 ZNF350 USPL1 | 1.33e-05 | 1285 | 227 | 23 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 AKAP8 MYO9B NACA DDX42 DDOST ABCB1 STXBP2 SACS HEATR5B NIPBL HSP90AB1 FLNC NUDT21 CEP290 BAZ1B IGF2R P4HB MACF1 TOP2B | 1.47e-05 | 1024 | 227 | 20 | 24711643 |
| Pubmed | Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. | 1.50e-05 | 8 | 227 | 3 | 23254285 | |
| Pubmed | Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. | 1.50e-05 | 8 | 227 | 3 | 20832730 | |
| Pubmed | Structural and functional coupling of Hsp90- and Sgt1-centred multi-protein complexes. | 1.50e-05 | 8 | 227 | 3 | 18818696 | |
| Pubmed | Distinct roles of molecular chaperones HSP90α and HSP90β in the biogenesis of KCNQ4 channels. | 1.50e-05 | 8 | 227 | 3 | 23431407 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | HSP90B1 RPN2 MYO9B IKZF1 PSME1 NR4A1 KDM6B DDOST MEX3B NOVA1 DNMT1 HSP90AB1 PLXNA3 DNAJC13 NUDT21 SLC25A33 ITSN1 RTN4 ZZZ3 GNB5 PDE4DIP | 1.72e-05 | 1124 | 227 | 21 | 21900206 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSP90B1 RPN2 NACA IKZF1 CLPX DDOST STXBP2 EIF2B4 NIPBL HSP90AA1 DNMT1 HSP90AB1 HSDL2 NUDT21 NOB1 WRN BAZ1B WDR5 PHF5A TSFM GTF2I PCCA TOP2B | 1.99e-05 | 1318 | 227 | 23 | 30463901 |
| Pubmed | 2.08e-05 | 51 | 227 | 5 | 36896912 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | CYP1A1 PDGFRA ABCB1 ABCB4 PPARGC1A CAPN2 WRN PPARGC1B ARNT IGF2R EXO1 | 2.20e-05 | 351 | 227 | 11 | 20453000 |
| Pubmed | 2.23e-05 | 128 | 227 | 7 | 30995482 | ||
| Pubmed | 2.24e-05 | 9 | 227 | 3 | 10585775 | ||
| Pubmed | Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice. | 2.24e-05 | 9 | 227 | 3 | 24705021 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 RPN2 VPS13C NACA DDX42 CLPX DDOST AP1G1 RBM19 NIPBL DNMT1 HSP90AB1 CUL1 HSDL2 NUDT21 RTN4 BAZ1B WDR5 PHF5A TSFM GTF2I IGF2R P4HB TOP2B | 2.31e-05 | 1425 | 227 | 24 | 30948266 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.39e-05 | 232 | 227 | 9 | 25515538 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | AKAP8 NACA DDX42 CLPX BLM WRAP73 NIPBL WDR62 HSP90AA1 CUL3 HSD17B7 WDR5 CPS1 SYF2 PHF5A GTF2I P4HB CEP135 CEP152 TOP2B PTTG2 | 2.56e-05 | 1155 | 227 | 21 | 20360068 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSP90B1 RPN2 PSME1 DDOST AP1G1 HSP90AA1 HSP90AB1 CUL1 FLNC RTN4 RICTOR DPP3 P4HB NANS MACF1 PCCA PGM2 | 2.57e-05 | 807 | 227 | 17 | 30575818 |
| Pubmed | ARHGAP32 RPN2 DDOST SH3BP4 RBM19 ARID5B CFAP70 DNAJC13 RTTN AFF3 ZC3H18 CFAP43 MACF1 | 2.62e-05 | 496 | 227 | 13 | 31343991 | |
| Pubmed | AKAP8 CMTR1 RPN2 NACA DDX42 CLPX DDOST AP1G1 DNMT1 CUL3 CUL1 RTN4 NOB1 BAZ1B GTF2I | 2.91e-05 | 653 | 227 | 15 | 33742100 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSP90B1 AKAP8 PDGFRA RPN2 DDX42 BLM RBM19 HSP90AA1 DNMT1 HSP90AB1 FLNC NUDT21 BAZ1B WDR5 GTF2I P4HB HSP90AB2P PCCA TOP2B | 3.02e-05 | 989 | 227 | 19 | 36424410 |
| Pubmed | A balance between elongation and trimming regulates telomere stability in stem cells. | 3.18e-05 | 10 | 227 | 3 | 27918544 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 3.23e-05 | 92 | 227 | 6 | 15840729 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPN2 KIF1B NACA PSME1 CLPX FCGBP AP1G1 RBM19 SCP2 HSP90AA1 DNMT1 HSP90AB1 FLNC DNAJC13 NUDT21 RTN4 CAPN2 ZC3H18 TSFM IGF2R P4HB ANO6 PCCA | 3.50e-05 | 1367 | 227 | 23 | 32687490 |
| Pubmed | 3.65e-05 | 94 | 227 | 6 | 35122331 | ||
| Pubmed | IL16 IKZF1 DDOST OARD1 ZNF438 CUL3 RBBP8 AFF3 RICTOR SYCP3 ST6GALNAC2 PPARGC1B ZZZ3 ARAP3 C9orf50 USPL1 ZMYM6 | 3.75e-05 | 832 | 227 | 17 | 36724073 | |
| Pubmed | DDX42 PSME1 DDOST BLM NIPBL HSP90AA1 DNMT1 CUL3 CUL1 CAPN2 BAZ1B WDR5 ZC3H18 PHF5A GTF2I ZNF532 NANS PRIM2 TOP2B | 4.22e-05 | 1014 | 227 | 19 | 32416067 | |
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 22087241 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 15466261 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 32150467 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 4.24e-05 | 2 | 227 | 2 | 21705081 | |
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 4.24e-05 | 2 | 227 | 2 | 9196326 | |
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 17018837 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 32054995 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 26950361 | ||
| Pubmed | 4.24e-05 | 2 | 227 | 2 | 8898203 | ||
| Pubmed | Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking. | 4.24e-05 | 2 | 227 | 2 | 38240799 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 4.24e-05 | 2 | 227 | 2 | 3458168 | |
| Pubmed | Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. | 4.24e-05 | 2 | 227 | 2 | 18971343 | |
| Interaction | CDKL4 interactions | 1.74e-07 | 13 | 219 | 5 | int:CDKL4 | |
| Interaction | YWHAZ interactions | ARHGAP32 HIVEP2 AKAP8 MAP6 DOCK11 KIF1B NR4A1 NEB LYST SH3BP4 NFATC3 SRGAP3 DMWD SUCO MEX3B WDR62 HSP90AA1 GAREM1 DNMT1 HSP90AB1 FOXO1 CUL3 MAPKAP1 CUL1 KIAA0930 WDR7 PSD3 RICTOR WDR5 ZC3H18 PABIR2 CSF2RB EXO1 MACF1 AKAP11 TANC1 | 2.85e-07 | 1319 | 219 | 36 | int:YWHAZ |
| Interaction | FBXL13 interactions | 4.43e-07 | 44 | 219 | 7 | int:FBXL13 | |
| Interaction | YWHAH interactions | ARHGAP32 HIVEP2 AKAP8 DOCK11 KIF1B LYST SH3BP4 NFATC3 DMWD SUCO MEX3B WDR62 HSP90AA1 DNMT1 HSP90AB1 OARD1 FOXO1 CUL3 MAPKAP1 KIAA0930 CEP290 PSD3 RICTOR PABIR2 CEP135 EXO1 MACF1 AKAP11 CEP152 TANC1 | 3.33e-06 | 1102 | 219 | 30 | int:YWHAH |
| Interaction | H1-2 interactions | HSP90B1 CMTR1 ABCA13 MYO9B IKZF1 NR4A1 KDM6B NEB TAOK2 BLM SRGAP3 RBM19 WRAP73 CUL3 CUL1 BAZ1B WDR5 ZC3H18 IGF2R AKAP11 TANC1 IPMK | 3.86e-06 | 666 | 219 | 22 | int:H1-2 |
| Interaction | YWHAG interactions | ARHGAP32 HIVEP2 AKAP8 DOCK11 KIF1B LYST SH3BP4 TAOK2 DLC1 NFATC3 DMWD SUCO MEX3B WDR62 HSP90AA1 GAREM1 DNMT1 HSP90AB1 FOXO1 CUL3 MAPKAP1 KIAA0930 PSD3 RICTOR PABIR2 P4HB N4BP2 EXO1 MACF1 AKAP11 TANC1 | 1.42e-05 | 1248 | 219 | 31 | int:YWHAG |
| Interaction | YWHAE interactions | ARHGAP32 HIVEP2 AKAP8 DOCK11 KIF1B LYST SH3BP4 TAOK2 SRGAP3 DMWD MEX3B WDR62 HSP90AA1 GAREM1 DNMT1 HSP90AB1 FOXO1 CUL3 MAPKAP1 CUL1 KIAA0930 CAPN2 PSD3 RICTOR ZC3H18 CFAP43 PABIR2 EXO1 MACF1 AKAP11 TANC1 | 1.60e-05 | 1256 | 219 | 31 | int:YWHAE |
| Interaction | DNA2 interactions | 2.43e-05 | 79 | 219 | 7 | int:DNA2 | |
| Interaction | ENO1 interactions | HSP90B1 MAP6 KIF1B IKZF1 NEB NFATC3 ADGRL2 DMWD HSP90AA1 DNMT1 HSP90AB1 FOXO1 CUL3 CUL1 FLNC HSDL2 RICTOR WDR5 ZC3H18 ACTR3B P4HB | 2.79e-05 | 701 | 219 | 21 | int:ENO1 |
| Interaction | HSP90AA2P interactions | 2.86e-05 | 55 | 219 | 6 | int:HSP90AA2P | |
| Interaction | SNRPE interactions | DDX42 IKZF1 HSP90AA1 CUL3 CUL1 CAPN2 WDR5 ZC3H18 SYF2 PHF5A ARHGAP12 CMTR2 TOP2B | 3.12e-05 | 305 | 219 | 13 | int:SNRPE |
| Interaction | YWHAQ interactions | ARHGAP32 HIVEP2 DOCK11 KIF1B NEB LYST SH3BP4 NFATC3 DMWD SUCO WDR62 HSP90AA1 GAREM1 DNMT1 HSP90AB1 FOXO1 CUL3 MAPKAP1 KIAA0930 PSD3 RICTOR CPS1 PABIR2 P4HB EXO1 MACF1 AKAP11 TANC1 | 3.32e-05 | 1118 | 219 | 28 | int:YWHAQ |
| Interaction | USF1 interactions | 3.91e-05 | 85 | 219 | 7 | int:USF1 | |
| Interaction | SBK2 interactions | 4.29e-05 | 7 | 219 | 3 | int:SBK2 | |
| Interaction | YWHAB interactions | ARHGAP32 AKAP8 DOCK11 KIF1B NEB LYST SH3BP4 NFATC3 DMWD SUCO MEX3B WDR62 HSP90AA1 HSP90AB1 FOXO1 CUL3 MAPKAP1 KIAA0930 PSD3 RICTOR PABIR2 P4HB EXO1 MACF1 AKAP11 TANC1 | 4.39e-05 | 1014 | 219 | 26 | int:YWHAB |
| Interaction | CALM1 interactions | TPP2 HSP90B1 DOCK11 MYO9B VPS13C KIF1B NACA NEB LYST RYR2 SCAPER HSP90AA1 CUL3 CUL1 DNAJC13 CEP290 ARNT GTF2I PDE4DIP | 5.72e-05 | 626 | 219 | 19 | int:CALM1 |
| Interaction | CREB3L3 interactions | 6.23e-05 | 63 | 219 | 6 | int:CREB3L3 | |
| Interaction | SIM1 interactions | 6.81e-05 | 8 | 219 | 3 | int:SIM1 | |
| Interaction | NLRC3 interactions | 6.81e-05 | 8 | 219 | 3 | int:NLRC3 | |
| Interaction | SFN interactions | ARHGAP32 HSP90B1 DOCK11 KIF1B NEB LYST SH3BP4 NFATC3 WDR62 FOXO1 MAPKAP1 KIAA0930 RICTOR ZC3H18 PABIR2 ARNT EXO1 MACF1 AKAP11 TANC1 | 7.14e-05 | 692 | 219 | 20 | int:SFN |
| Interaction | RICTOR interactions | HSP90B1 NACA CLPX CHUK HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P CUL3 MAPKAP1 CUL1 FLNC RICTOR WDR5 CPS1 RAB3GAP1 GTF2I IGF2R P4HB NANS HSP90AB2P | 8.70e-05 | 759 | 219 | 21 | int:RICTOR |
| Interaction | BRCA1 interactions | TPP2 HSP90B1 AKAP8 PDGFRA KIF1B NACA DDX42 ACTN3 CLPX BLM NIPBL HSP90AA1 DNMT1 HSP90AB1 MAPKAP1 FLNC RBBP8 WRN RICTOR SYCP3 WDR5 ARNT GTF2I ZZZ3 P4HB EXO1 ZNF350 HSP90AB2P TOP2B | 9.19e-05 | 1249 | 219 | 29 | int:BRCA1 |
| Interaction | GRIN2B interactions | 1.04e-04 | 170 | 219 | 9 | int:GRIN2B | |
| Interaction | DLGAP3 interactions | 1.11e-04 | 44 | 219 | 5 | int:DLGAP3 | |
| Interaction | BRAF interactions | HSP90B1 AKAP8 MYO9B HSP90AA1 HSP90AB1 HSP90AB3P DNAJC13 RAB3GAP1 P4HB CTSV | 1.13e-04 | 212 | 219 | 10 | int:BRAF |
| Interaction | KCTD13 interactions | TPP2 ARHGAP32 HSP90B1 IL16 MAP6 KIF1B ANKS1B ACTN3 AP1G1 SACS SRGAP3 SCAPER DLG2 DNAH6 HSP90AA1 HSP90AB1 CUL3 FLNC DNAJC13 WDR7 NUDT21 ITSN1 RTN4 CAPN2 PSD3 ACTR3B SLC4A1 P4HB GNB5 MACF1 TANC1 | 1.13e-04 | 1394 | 219 | 31 | int:KCTD13 |
| Interaction | RYR3 interactions | 1.22e-04 | 24 | 219 | 4 | int:RYR3 | |
| Interaction | HEATR5A interactions | 1.43e-04 | 25 | 219 | 4 | int:HEATR5A | |
| Cytoband | 19q13.41 | 4.45e-05 | 78 | 227 | 5 | 19q13.41 | |
| GeneFamily | Heat shock 90kDa proteins | 5.64e-06 | 5 | 151 | 3 | 586 | |
| GeneFamily | WD repeat domain containing | 7.19e-05 | 262 | 151 | 10 | 362 | |
| GeneFamily | Sialyltransferases | 5.87e-04 | 20 | 151 | 3 | 438 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 6.82e-04 | 5 | 151 | 2 | 1333 | |
| GeneFamily | RecQ like helicases | 6.82e-04 | 5 | 151 | 2 | 1049 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 7.99e-04 | 50 | 151 | 4 | 721 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF140 ZNF486 HIVEP2 ZNF613 IKZF1 ZNF600 SCAPER ZNF480 ZNF615 ZNF782 ZNF438 ZNF484 ZNF532 EGR3 ZNF350 | 1.01e-03 | 718 | 151 | 15 | 28 |
| GeneFamily | Cullins | 1.88e-03 | 8 | 151 | 2 | 1032 | |
| GeneFamily | ATP binding cassette subfamily B | 3.63e-03 | 11 | 151 | 2 | 806 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 4.33e-03 | 12 | 151 | 2 | 445 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP2 MYO9B DDX42 BLM DLC1 SACS NFATC3 RIN2 ARNT2 ARID5B SUCO NIPBL CUL1 DNAJC13 WDR7 ITSN1 WRN PSD3 BAZ1B KRIT1 RAB3GAP1 ZZZ3 IGF2R PRIM2 ARHGAP12 CEP135 MACF1 AKAP11 PCCA | 1.70e-10 | 856 | 219 | 29 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HSP90B1 ZNF486 VPS13C BLM PPARGC1A SACS SCP2 SUCO NIPBL HSP90AA1 GAREM1 DNAJC13 RBBP8 CEP290 WRN BAZ1B KRIT1 ZZZ3 AKAP11 PCCA CTSV TOP2B | 3.79e-08 | 656 | 219 | 22 | M18979 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP2 KIF1B LYST ABCB1 ST3GAL6 RIN2 SCN7A ARID5B MED12L HEATR5B HSP90AA1 HSDL2 ITSN1 PSD3 RICTOR HEATR5A ATP10A KRIT1 ARNT ST6GALNAC3 PDE4DIP MACF1 TANC1 PGM2 PCOLCE | 5.99e-08 | 854 | 219 | 25 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP2 KIF1B LYST ABCB1 ST3GAL6 RIN2 SCN7A ARID5B MED12L HEATR5B HSP90AA1 HSDL2 ITSN1 PSD3 RICTOR HEATR5A ATP10A KRIT1 ARNT ST6GALNAC3 PDE4DIP MACF1 TANC1 PGM2 PCOLCE | 1.26e-07 | 888 | 219 | 25 | MM1018 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 6.85e-07 | 60 | 219 | 7 | M1401 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.17e-06 | 75 | 219 | 7 | MM605 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HIVEP2 MAN2A2 MAP6 VPS13C LYST SCAPER PLCB1 HCFC2 SUCO HSP90AA1 HSP90AB1 FOXO1 CACNA1D WDR7 RBBP8 RTN4 PSD3 PRSS23 RAB3GAP1 ZZZ3 PDE4DIP AKAP11 UNC80 | 4.91e-06 | 946 | 219 | 23 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP2 BLM DLC1 ARID5B CUL1 DNAJC13 WDR7 ITSN1 WRN KRIT1 RAB3GAP1 ZZZ3 PRIM2 ARHGAP12 CEP135 | 9.83e-06 | 466 | 219 | 15 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | HIVEP2 KIF1B ST3GAL6 DLG2 PSD3 ATP10A TENM3 ST6GALNAC3 MACF1 TANC1 | 1.27e-05 | 212 | 219 | 10 | M39221 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 1.67e-05 | 174 | 219 | 9 | M40888 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP | 4.80e-05 | 199 | 219 | 9 | M7652 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | HIVEP2 PSME1 ACSL1 RBBP8 KRIT1 PPARGC1B CSF2RB ABHD17B MAPKBP1 | 4.99e-05 | 200 | 219 | 9 | M3508 |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 4.99e-05 | 200 | 219 | 9 | M8312 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN | 4.99e-05 | 200 | 219 | 9 | M8643 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 4.99e-05 | 200 | 219 | 9 | M6044 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_DN | 9.04e-05 | 11 | 219 | 3 | M2203 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | PDGFRA NACA IKZF1 BLM HSP90AA1 HSP90AB1 FOXO1 AFF3 WRN ARNT PDE4DIP | 9.35e-05 | 323 | 219 | 11 | M9150 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | CNTNAP3B F8 ST3GAL6 ARID5B THEMIS2 FLNC HSDL2 ITSN1 PRSS23 PPARGC1B ABHD17B GNB5 | 9.70e-05 | 382 | 219 | 12 | M45756 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 9.88e-05 | 127 | 219 | 7 | M40905 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | TPP2 CYP1A1 IL16 NACA IKZF1 PSME1 CLPX CHUK BLM NFATC3 DNMT1 CA7 OARD1 GPLD1 KIAA0930 DNAJC13 RBBP8 BAZ1B TSFM ARNT GTF2H3 ZZZ3 CSF2RB CEP135 TOP2B PTTG2 | 1.11e-04 | 1394 | 219 | 26 | M9585 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP | 1.13e-04 | 174 | 219 | 8 | M8885 | |
| Coexpression | PHESSE_TARGETS_OF_APC_AND_MBD2_DN | 1.20e-04 | 12 | 219 | 3 | MM891 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 1.37e-04 | 179 | 219 | 8 | M41745 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.37e-04 | 179 | 219 | 8 | M39308 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.43e-04 | 180 | 219 | 8 | M8239 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 1.67e-04 | 97 | 219 | 6 | MM1318 | |
| Coexpression | GUO_TARGETS_OF_IRS1_AND_IRS2 | 1.67e-04 | 97 | 219 | 6 | M2434 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.79e-04 | 186 | 219 | 8 | M8175 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | CYP1A1 KDM6B LYST DLC1 RIN2 ARID5B AIFM3 HCFC2 ZNF703 PRSS23 ST6GALNAC2 GRHL3 | 1.64e-06 | 210 | 215 | 12 | ratio_ECTO_vs_SC_1000_K4 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | HIVEP2 PDGFRA DOCK11 SRGAP3 RIN2 ADGRL2 HSDL2 RTN4 AFF3 MAPKBP1 | 2.29e-05 | 188 | 215 | 10 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | LYST CHUK BLM ACSL1 ZNF600 SCAPER MED12L HSP90AA1 NOVA1 DNAJC13 RBBP8 SYCP3 WDR5 ACTR3B ATP10A CYP2R1 PRIM2 ERCC6L2 EXO1 AKAP11 ZMYM6 IPMK | 3.25e-05 | 820 | 215 | 22 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | HIVEP2 PDGFRA DOCK11 SRGAP3 RIN2 ADGRL2 NOVA1 FOXO1 HSDL2 AFF3 MCM9 MAPKBP1 | 3.99e-05 | 288 | 215 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | HIVEP2 PDGFRA DOCK11 ACTN3 SRGAP3 RIN2 ADGRL2 SUCO MEX3B NOVA1 FOXO1 ZNF703 HSDL2 RTN4 AFF3 ATP10A ARAP3 MCM9 TANC1 MAPKBP1 ZMYM6 | 5.75e-05 | 791 | 215 | 21 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | CNTNAP3B DYSF C2CD4C ABCB1 PLCB1 ADGRL2 A1CF PRSS23 ST6GALNAC3 TANC1 | 1.12e-08 | 165 | 222 | 10 | 84e553d699ac56df89a77248f7308b9133e1b683 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.87e-08 | 188 | 222 | 10 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA13 KIF1B DYSF ACSL1 STXBP2 FCGR3B IGF2R ARAP3 SLC16A3 UNC80 | 4.50e-08 | 191 | 222 | 10 | d4f77c73311d1149466bbfe4adbd6a301946ec90 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ANKS1B SRGAP3 ARNT2 ADGRL2 CACNA1D AFF3 PSD3 MACF1 TANC1 PCCA | 5.21e-08 | 194 | 222 | 10 | b1bb0f846d2865efdd9bc8842b16b9d069785882 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-07 | 182 | 222 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 4.18e-07 | 186 | 222 | 9 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.78e-07 | 189 | 222 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-07 | 189 | 222 | 9 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.00e-07 | 190 | 222 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | ARHGAP32 MAP6 ABCA13 CFAP70 PSD3 MUC16 CFAP43 CFAP52 TP53AIP1 | 5.45e-07 | 192 | 222 | 9 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.70e-07 | 193 | 222 | 9 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.21e-07 | 195 | 222 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.21e-07 | 195 | 222 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.21e-07 | 195 | 222 | 9 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.21e-07 | 195 | 222 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.76e-07 | 197 | 222 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Transverse-(2)_B_cell-(21)_B_cell_IgG_Plasma|Transverse / shred on region, Cell_type, and subtype | 7.05e-07 | 198 | 222 | 9 | d6052b5a44246798e90f4779cd940ffac7539fcd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-07 | 198 | 222 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|Transverse / Region, Cell class and subclass | 7.05e-07 | 198 | 222 | 9 | a4ece1fe3d15acfde0e6ff14cddb3a3d16f61ce0 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 7.36e-07 | 199 | 222 | 9 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | HSP90B1 VPS13C IKZF1 ARID5B NIPBL HSP90AA1 HSP90AB1 CAPN2 MACF1 | 7.67e-07 | 200 | 222 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-06 | 163 | 222 | 8 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 163 | 222 | 8 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 168 | 222 | 8 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 169 | 222 | 8 | bca5322880c09b78ef10d9dda6420a80c1ba7e62 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-06 | 171 | 222 | 8 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-06 | 171 | 222 | 8 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.49e-06 | 172 | 222 | 8 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 2.83e-06 | 175 | 222 | 8 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-06 | 176 | 222 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-06 | 176 | 222 | 8 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-06 | 176 | 222 | 8 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-06 | 124 | 222 | 7 | 80526f503e1477b9455d10f27f7e6b56caea3a66 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-06 | 179 | 222 | 8 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-06 | 179 | 222 | 8 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-06 | 179 | 222 | 8 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 3.49e-06 | 180 | 222 | 8 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.95e-06 | 183 | 222 | 8 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-06 | 184 | 222 | 8 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.28e-06 | 185 | 222 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.45e-06 | 186 | 222 | 8 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.63e-06 | 187 | 222 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.82e-06 | 188 | 222 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.82e-06 | 188 | 222 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.82e-06 | 188 | 222 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.82e-06 | 188 | 222 | 8 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.82e-06 | 188 | 222 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-06 | 189 | 222 | 8 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 190 | 222 | 8 | 240923769fef18eaf73d2efa3d5f745f5533b0ce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.21e-06 | 190 | 222 | 8 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.21e-06 | 190 | 222 | 8 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 190 | 222 | 8 | 9df9b9e91c97e504c189d6055a6aabc54ad17cec | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.41e-06 | 191 | 222 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.41e-06 | 191 | 222 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.62e-06 | 192 | 222 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-06 | 192 | 222 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.62e-06 | 192 | 222 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.84e-06 | 193 | 222 | 8 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-06 | 193 | 222 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.84e-06 | 193 | 222 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 193 | 222 | 8 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-06 | 194 | 222 | 8 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 6.07e-06 | 194 | 222 | 8 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 194 | 222 | 8 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.30e-06 | 195 | 222 | 8 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-06 | 195 | 222 | 8 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 6.30e-06 | 195 | 222 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.30e-06 | 195 | 222 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-06 | 195 | 222 | 8 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.30e-06 | 195 | 222 | 8 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 195 | 222 | 8 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.30e-06 | 195 | 222 | 8 | b0dbaae86f5703ab62f925e0f36500274044884a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.30e-06 | 195 | 222 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.30e-06 | 195 | 222 | 8 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.54e-06 | 196 | 222 | 8 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.54e-06 | 196 | 222 | 8 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.54e-06 | 196 | 222 | 8 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 6.54e-06 | 196 | 222 | 8 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.54e-06 | 196 | 222 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.79e-06 | 197 | 222 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.79e-06 | 197 | 222 | 8 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.79e-06 | 197 | 222 | 8 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.79e-06 | 197 | 222 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.04e-06 | 198 | 222 | 8 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.04e-06 | 198 | 222 | 8 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.04e-06 | 198 | 222 | 8 | 8de1808898e63cd74b131baeb9610e88363a41d1 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-06 | 198 | 222 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.04e-06 | 198 | 222 | 8 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.31e-06 | 199 | 222 | 8 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 7.31e-06 | 199 | 222 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 7.31e-06 | 199 | 222 | 8 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.31e-06 | 199 | 222 | 8 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.31e-06 | 199 | 222 | 8 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 7.31e-06 | 199 | 222 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.31e-06 | 199 | 222 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 7.31e-06 | 199 | 222 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.32e-06 | 142 | 222 | 7 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 7.32e-06 | 142 | 222 | 7 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.58e-06 | 200 | 222 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| Drug | PeCDD | 2.00e-07 | 27 | 222 | 6 | CID000038439 | |
| Drug | tamoxifen aziridine | 1.94e-06 | 22 | 222 | 5 | CID003033894 | |
| Drug | S2A | 2.46e-06 | 23 | 222 | 5 | CID016058643 | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | ARHGAP32 MYO9B NFATC3 RIN2 CUL3 A1CF AFF3 BAZ1B CPS1 ARNT MAPKBP1 | 3.59e-06 | 195 | 222 | 11 | 6163_DN |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | CYP1A1 LYST RYR2 RBM19 RIN2 PLCB1 DMWD OARD1 TSFM GTF2I ZNF350 | 3.77e-06 | 196 | 222 | 11 | 3306_DN |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | MYO9B IKZF1 NEB HOXC8 RBM19 RIN2 SCAPER KIAA0930 ARNT GTF2H3 SLC16A3 | 3.77e-06 | 196 | 222 | 11 | 3327_DN |
| Drug | fulvestrant | CYP1A1 HSP90B1 PDGFRA NR4A1 ABCB1 BLM PPARGC1A ARNT2 HSP90AA1 DNMT1 HSP90AB1 FLNC RBBP8 PRSS23 IGF2R EGR3 TOP2B | 5.93e-06 | 484 | 222 | 17 | ctd:C070081 |
| Drug | Maneb | CYP1A1 PDGFRA PDYN KIF1B NR4A1 ARNT2 AIF1 NIPBL HSP90AA1 RTN4 CEP290 DLL1 NPS MACF1 | 7.83e-06 | 344 | 222 | 14 | ctd:D008344 |
| Drug | p-iodophenol | 8.27e-06 | 29 | 222 | 5 | CID000010894 | |
| Drug | 1uyd | 9.01e-06 | 5 | 222 | 3 | CID000448970 | |
| Drug | AC1L1IZ2 | HSP90B1 MYO9B KIF1B ANKS1B CLPX RYR2 RBM19 HSP90AA1 HSP90AA2P MYH7B CPS1 KRIT1 TOP2B | 9.82e-06 | 304 | 222 | 13 | CID000004795 |
| Drug | benzo(c)phenanthrene | 1.60e-05 | 33 | 222 | 5 | CID000009136 | |
| Drug | perfluoro-n-nonanoic acid | 1.63e-05 | 114 | 222 | 8 | ctd:C101816 | |
| Drug | geldanamycin | TPP2 CYP1A1 HSP90B1 DDX42 CHUK ZNF480 NIPBL HSP90AA1 HSP90AB1 DNAJC13 RTTN AFF3 PDE4DIP ERCC6L2 | 1.83e-05 | 371 | 222 | 14 | ctd:C001277 |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | CYP1A1 NFATC3 PLCB1 GPLD1 PSD3 BAZ1B GTF2H3 ABHD17B CEP135 ZMYM6 | 1.83e-05 | 190 | 222 | 10 | 5271_DN |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A | MYO9B TAOK2 PLCB1 FOXO1 CUL3 CAPN2 CPS1 ST6GALNAC2 KRIT1 ZMYM6 | 2.09e-05 | 193 | 222 | 10 | 4616_DN |
| Drug | Isoproterenol | CYP1A1 HSP90B1 KIF1B NR4A1 KDM6B NEB DDOST RYR2 ABCB4 PPARGC1A ARNT2 SCN7A ARID5B AIF1 HEATR5B HSP90AA1 FOXO1 MYH7B CAPN2 CPS1 TSFM PPARGC1B CSF2RB P4HB ARHGAP12 | 2.12e-05 | 1016 | 222 | 25 | ctd:D007545 |
| Drug | Llvy-mca | 2.15e-05 | 35 | 222 | 5 | CID000121886 | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | HSP90B1 MYO9B LYST TAOK2 RIN2 PLCB1 PLXNA3 BAZ1B SLC16A3 CEP152 | 2.19e-05 | 194 | 222 | 10 | 3303_DN |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | KIF1B TAOK2 RBM19 SCAPER ACTR3B CPS1 RAB3GAP1 ARNT CYP2R1 CEP152 | 2.19e-05 | 194 | 222 | 10 | 6201_DN |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A | 2.29e-05 | 195 | 222 | 10 | 2132_UP | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | DYSF RBM19 ZNF480 FOXO1 GPLD1 A1CF PSD3 TENM3 PDE4DIP CEP135 | 2.29e-05 | 195 | 222 | 10 | 5269_DN |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | ZNF140 PDGFRA IKZF1 DLC1 ST3GAL6 NFATC3 SRGAP3 GPLD1 KRIT1 PDE4DIP | 2.39e-05 | 196 | 222 | 10 | 4574_UP |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | RYR2 TAOK2 STXBP2 NFATC3 RIN2 SCAPER WDR62 ARNT CEP135 ZNF350 | 2.39e-05 | 196 | 222 | 10 | 5528_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | IKZF1 NR4A1 NEB LYST RBM19 SCAPER PLCB1 ZNF480 GPLD1 MAPKBP1 | 2.50e-05 | 197 | 222 | 10 | 5436_DN |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | KIF1B NR4A1 GAREM1 HSDL2 ITSN1 CEP290 AFF3 KRIT1 SLC16A3 EGR3 | 2.61e-05 | 198 | 222 | 10 | 1170_UP |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | CYP1A1 MYO9B LYST SCAPER GAREM1 CEP290 PSD3 ARNT ABHD17B SLC16A3 | 2.72e-05 | 199 | 222 | 10 | 5207_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | ARHGAP32 NR4A1 NFATC3 SCAPER AFF3 RAB3GAP1 ARNT SLC16A3 CEP152 CTSV | 2.72e-05 | 199 | 222 | 10 | 6168_DN |
| Drug | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 3.11e-05 | 7 | 222 | 3 | CID000042836 | |
| Drug | dienochlor | 3.11e-05 | 7 | 222 | 3 | CID000016686 | |
| Drug | 17-aminogeldanamycin | 3.11e-05 | 7 | 222 | 3 | CID000429444 | |
| Drug | NSC330499 | 3.11e-05 | 7 | 222 | 3 | CID000433447 | |
| Drug | Raloxifene Hydrochloride | CYP1A1 HSP90B1 MAN2A2 PDGFRA PDYN PSME1 NR4A1 F8 ABCB1 ACSL1 AP1G1 ARNT2 ARID5B HSP90AB1 FOXO1 FLNC RBBP8 CAPN2 PRSS23 EGR3 TOP2B PCOLCE | 3.64e-05 | 857 | 222 | 22 | ctd:D020849 |
| Drug | Sulpiride | 4.20e-05 | 40 | 222 | 5 | ctd:D013469 | |
| Drug | AC1L85AO | 4.48e-05 | 66 | 222 | 6 | CID000372705 | |
| Drug | tBCEU | 4.94e-05 | 8 | 222 | 3 | CID000164059 | |
| Drug | phenyldichloroarsine | 4.94e-05 | 8 | 222 | 3 | CID000012762 | |
| Drug | 9-phenanthrol | 4.94e-05 | 8 | 222 | 3 | CID000010229 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.51e-05 | 174 | 222 | 9 | 7530_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.51e-05 | 174 | 222 | 9 | 5745_DN | |
| Drug | CCT018159 | 5.61e-05 | 22 | 222 | 4 | CID005327091 | |
| Drug | methyl methacrylate | 6.73e-05 | 23 | 222 | 4 | CID000006658 | |
| Drug | hyperforin | 6.73e-05 | 23 | 222 | 4 | ctd:C001654 | |
| Drug | beryllium fluoride | 6.83e-05 | 103 | 222 | 7 | CID000024589 | |
| Drug | Etoposide | TPP2 MAGEA6 HSP90B1 ABCB1 BLM PPARGC1A HSP90AA1 DNMT1 FOXO1 FLNC WRN EI24 CPS1 ST6GALNAC2 PPARGC1B MACF1 TOP2B | 6.86e-05 | 587 | 222 | 17 | ctd:D005047 |
| Drug | 5,8-quinolinedione | 7.36e-05 | 9 | 222 | 3 | CID000388306 | |
| Drug | 11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol | 7.36e-05 | 9 | 222 | 3 | ctd:C541120 | |
| Drug | 3-amino-5-chlorobenzoic acid | 9.46e-05 | 2 | 222 | 2 | CID010986726 | |
| Drug | monocillin III | 9.46e-05 | 2 | 222 | 2 | CID006478910 | |
| Drug | pochonin A | 9.46e-05 | 2 | 222 | 2 | CID006478909 | |
| Drug | PU-H71 | 9.46e-05 | 2 | 222 | 2 | CID009549213 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 9.46e-05 | 2 | 222 | 2 | DB02754 | |
| Drug | 1uyc | 9.46e-05 | 2 | 222 | 2 | CID000448969 | |
| Drug | PU-9 | 9.46e-05 | 2 | 222 | 2 | CID000448971 | |
| Drug | P u 0 | 9.46e-05 | 2 | 222 | 2 | CID000448974 | |
| Drug | AC1L8X8E | 9.46e-05 | 2 | 222 | 2 | CID000434318 | |
| Drug | AC1L8X8B | 9.46e-05 | 2 | 222 | 2 | CID000434317 | |
| Drug | 2qf6 | 9.46e-05 | 2 | 222 | 2 | CID013373715 | |
| Drug | Geldanamycin | 9.46e-05 | 2 | 222 | 2 | DB02424 | |
| Drug | 3-methyl-picolinic acid | 9.46e-05 | 2 | 222 | 2 | CID000268757 | |
| Drug | AC1L9236 | 9.46e-05 | 2 | 222 | 2 | CID000411789 | |
| Drug | METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE | 9.46e-05 | 2 | 222 | 2 | DB08464 | |
| Drug | 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE | 9.46e-05 | 2 | 222 | 2 | DB08465 | |
| Drug | CHEBI:42139 | 9.46e-05 | 2 | 222 | 2 | CID011562562 | |
| Drug | psorospermin | 9.46e-05 | 2 | 222 | 2 | CID000126451 | |
| Drug | Rifabutin | 9.46e-05 | 2 | 222 | 2 | DB00615 | |
| Drug | moflomycin | 9.46e-05 | 2 | 222 | 2 | CID000163775 | |
| Drug | 2qfo | 9.46e-05 | 2 | 222 | 2 | CID000600769 | |
| Drug | 3eko | 9.46e-05 | 2 | 222 | 2 | CID011160307 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 9.46e-05 | 2 | 222 | 2 | DB07877 | |
| Drug | NSC348400 | 9.46e-05 | 2 | 222 | 2 | CID000335945 | |
| Drug | 1uyi | 9.46e-05 | 2 | 222 | 2 | CID005289232 | |
| Drug | KW-2170 | 9.46e-05 | 2 | 222 | 2 | CID005747700 | |
| Drug | 1,9-dideoxyforskolin | 9.46e-05 | 2 | 222 | 2 | ctd:C047983 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 9.46e-05 | 2 | 222 | 2 | DB07594 | |
| Drug | NSC683666 | 9.46e-05 | 2 | 222 | 2 | CID005469153 | |
| Drug | H 64 | 9.46e-05 | 2 | 222 | 2 | CID006914564 | |
| Drug | morpholinyldoxorubicin | 9.46e-05 | 2 | 222 | 2 | CID000092398 | |
| Drug | SureCN4151355 | 9.46e-05 | 2 | 222 | 2 | CID015942101 | |
| Drug | PU-6 | 1.04e-04 | 10 | 222 | 3 | CID000448968 | |
| Drug | AC1MZ4R5 | 1.04e-04 | 10 | 222 | 3 | CID003842392 | |
| Drug | formetanate | 1.04e-04 | 10 | 222 | 3 | CID000031099 | |
| Drug | alternariol monomethyl ether | 1.04e-04 | 10 | 222 | 3 | ctd:C018206 | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.08e-04 | 190 | 222 | 9 | 7154_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 191 | 222 | 9 | 6024_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 191 | 222 | 9 | 7165_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | HSP90B1 PLCB1 ZNF480 RAB3GAP1 ARNT GTF2I ABHD17B SLC16A3 PDE4DIP | 1.17e-04 | 192 | 222 | 9 | 2766_DN |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 5351_UP | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 1840_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.27e-04 | 194 | 222 | 9 | 862_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 4662_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 2278_DN | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; HL60; HG-U133A | 1.37e-04 | 196 | 222 | 9 | 2010_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 5005_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | HIVEP2 KDM6B NFATC3 SCAPER NIPBL CUL3 NUDT21 RAB3GAP1 MAPKBP1 | 1.37e-04 | 196 | 222 | 9 | 1861_DN |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | IKZF1 NR4A1 TAOK2 SCAPER PLCB1 ST6GALNAC2 GTF2I GNB5 PDE4DIP | 1.37e-04 | 196 | 222 | 9 | 7520_DN |
| Drug | NSC91998 | 1.42e-04 | 81 | 222 | 6 | CID000005668 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6169_DN | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6947_UP | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; HL60; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6125_DN | |
| Disease | Primary microcephaly | 4.78e-07 | 22 | 216 | 5 | C0431350 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.78e-07 | 68 | 216 | 7 | DOID:5419 (implicated_via_orthology) | |
| Disease | urate measurement | CYP1A1 DYSF NFATC3 EIF2B4 SCAPER PIP5KL1 DLG2 HEATR5B ADGRL2 HSP90AB3P DNAJC13 A1CF NUDT21 PSD3 BAZ1B CPS1 SYF2 TSFM SLC4A1 ANO6 | 1.07e-05 | 895 | 216 | 20 | EFO_0004531 |
| Disease | FEV/FEC ratio | HIVEP2 VPS13C KIF1B ANKS1B NEB PPARGC1A FCGBP DLC1 FCGR3B SRGAP3 SCAPER ZNF438 FOXO1 CACNA1D AFF3 PRSS23 PPARGC1B GTF2I EGR3 ARHGAP12 ERCC6L2 HSP90AB2P TOP2B HDC | 1.28e-05 | 1228 | 216 | 24 | EFO_0004713 |
| Disease | cancer (implicated_via_orthology) | DLG2 NIPBL HSP90AA1 HSP90AA2P HSP90AB1 HSP90AB3P DLL1 MACF1 HSP90AB2P TOP2B | 3.10e-05 | 268 | 216 | 10 | DOID:162 (implicated_via_orthology) |
| Disease | triacylglycerol 50:0 measurement | 5.33e-05 | 2 | 216 | 2 | EFO_0021480 | |
| Disease | primary autosomal recessive microcephaly 2 with or without cortical malformations (implicated_via_orthology) | 5.33e-05 | 2 | 216 | 2 | DOID:0070293 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 5.75e-05 | 29 | 216 | 4 | DOID:767 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA13 ABCA10 ABCB1 ABCB4 DLC1 SACS ZNF480 FLNC RTN4 WRN ARNT ZZZ3 ARAP3 GNB5 EXO1 HDC | 6.63e-05 | 702 | 216 | 16 | C0009402 |
| Disease | bitter non-alcoholic beverage consumption measurement | 8.55e-05 | 32 | 216 | 4 | EFO_0010093 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 8.55e-05 | 61 | 216 | 5 | C1961102 | |
| Disease | Schizophrenia | ARHGAP32 MAP6 ABCA13 MYO9B PDYN ABCB1 PPARGC1A SRGAP3 PLCB1 ZNF480 DLG2 DNMT1 RTN4 PSD3 CSF2RB NPS EGR3 ERVK-8 | 9.66e-05 | 883 | 216 | 18 | C0036341 |
| Disease | Intellectual Disability | HIVEP2 KDM6B SACS SRGAP3 SCAPER MED12L WDR62 RTTN AFF3 DLL1 MACF1 ZMYM6 | 1.24e-04 | 447 | 216 | 12 | C3714756 |
| Disease | total blood protein measurement | IKZF1 DYSF FCGR3B NFATC3 ARID5B ZNF438 DNAJC13 A1CF AFF3 CPS1 SLC4A1 MACF1 | 1.29e-04 | 449 | 216 | 12 | EFO_0004536 |
| Disease | Malignant neoplasm of breast | CYP1A1 AKAP8 DYSF ABCB1 SRGAP3 PLCB1 SCP2 NIPBL HSP90AA1 DNMT1 THEMIS2 ZNF438 DLL1 PPARGC1B ARAP3 SLC16A3 ZNF532 N4BP2 EXO1 MACF1 | 1.34e-04 | 1074 | 216 | 20 | C0006142 |
| Disease | Autosomal recessive primary microcephaly | 1.65e-04 | 15 | 216 | 3 | cv:C3711387 | |
| Disease | pancreatitis (biomarker_via_orthology) | 1.88e-04 | 39 | 216 | 4 | DOID:4989 (biomarker_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | AKAP8 MYO9B IKZF1 CLPX NEB FCGR3B PLCB1 MEX3B HSP90AB1 FOXO1 CUL1 DNAJC13 ITSN1 RTTN PSD3 CPS1 SYF2 SLC4A1 EXO1 MACF1 | 1.95e-04 | 1105 | 216 | 20 | EFO_0004528 |
| Disease | Colorectal Neoplasms | 2.19e-04 | 277 | 216 | 9 | C0009404 | |
| Disease | grey matter volume measurement | 3.01e-04 | 44 | 216 | 4 | EFO_0005420 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.09e-04 | 80 | 216 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | executive function measurement, cognitive function measurement | 3.17e-04 | 4 | 216 | 2 | EFO_0008354, EFO_0009332 | |
| Disease | otosclerosis | 3.27e-04 | 81 | 216 | 5 | EFO_0004213 | |
| Disease | Major Depressive Disorder | 4.48e-04 | 243 | 216 | 8 | C1269683 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.94e-04 | 50 | 216 | 4 | DOID:3770 (biomarker_via_orthology) | |
| Disease | L2 Acute Lymphoblastic Leukemia | 4.94e-04 | 50 | 216 | 4 | C0023453 | |
| Disease | Werner syndrome (implicated_via_orthology) | 5.26e-04 | 5 | 216 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | Lewy Body Disease | 5.38e-04 | 22 | 216 | 3 | C0752347 | |
| Disease | Autosomal Recessive Primary Microcephaly | 5.38e-04 | 22 | 216 | 3 | C3711387 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 5.74e-04 | 52 | 216 | 4 | C0023452 | |
| Disease | chronic obstructive pulmonary disease | HIVEP2 KIF1B DLC1 SRGAP3 DLG2 DMWD NOVA1 CACNA1D AFF3 PRSS23 PPARGC1B ERCC6L2 HSP90AB2P TOP2B | 5.90e-04 | 688 | 216 | 14 | EFO_0000341 |
| Disease | clonal hematopoiesis mutation measurement | 7.11e-04 | 55 | 216 | 4 | EFO_0020949 | |
| Disease | forced expiratory volume | AK9 ACTN3 RYR2 ADGRL2 HSP90AA1 GAREM1 CACNA1D RBBP8 NOB1 AFF3 PSD3 PRSS23 ARHGAP12 ERCC6L2 TOP2B | 7.58e-04 | 789 | 216 | 15 | EFO_0004314 |
| Disease | Fetal Mummification | 7.85e-04 | 6 | 216 | 2 | C2718076 | |
| Disease | Bradycardia | 8.88e-04 | 26 | 216 | 3 | C0428977 | |
| Disease | complex trait | 9.12e-04 | 271 | 216 | 8 | EFO_0010578 | |
| Disease | Bone Diseases, Developmental | 9.94e-04 | 27 | 216 | 3 | C0005941 | |
| Disease | Acute lymphocytic leukemia | 1.09e-03 | 7 | 216 | 2 | C0023449 | |
| Disease | acute lymphoblastic leukemia | 1.41e-03 | 66 | 216 | 4 | EFO_0000220 | |
| Disease | platelet component distribution width | CYP1A1 HIVEP2 MYO9B IKZF1 SLFN14 DLC1 FCGR3B RIN2 PLCB1 AIF1 THEMIS2 RTTN CPS1 MACF1 | 1.43e-03 | 755 | 216 | 14 | EFO_0007984 |
| Disease | mean platelet volume | ARHGAP32 HIVEP2 DOCK11 MYO9B KIF1B NACA IKZF1 SLFN14 ACSL1 ST3GAL6 PLCB1 AIF1 RTTN AFF3 PSD3 CPS1 MCM9 | 1.45e-03 | 1020 | 216 | 17 | EFO_0004584 |
| Disease | Williams Syndrome | 1.45e-03 | 8 | 216 | 2 | C0175702 | |
| Disease | late-onset Alzheimers disease | 1.47e-03 | 292 | 216 | 8 | EFO_1001870 | |
| Disease | immature platelet fraction | 1.54e-03 | 114 | 216 | 5 | EFO_0009187 | |
| Disease | apolipoprotein A 1 measurement | MAN2A2 CMTR1 IKZF1 TAOK2 DLC1 FCGR3B NFATC3 EIF2B4 AFF3 PSD3 CPS1 TSFM PPARGC1B NANS MACF1 | 1.55e-03 | 848 | 216 | 15 | EFO_0004614 |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.63e-03 | 170 | 216 | 6 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | advanced glycation end-product measurement | 1.86e-03 | 9 | 216 | 2 | EFO_0007819 | |
| Disease | gallbladder neoplasm | 1.86e-03 | 9 | 216 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.86e-03 | 9 | 216 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | encephalitis (biomarker_via_orthology) | 1.86e-03 | 9 | 216 | 2 | DOID:9588 (biomarker_via_orthology) | |
| Disease | corneal resistance factor | ABCA10 ARNT2 ARID5B HSP90AB3P FOXO1 HSD17B7 AFF3 SLC4A1 SLC16A3 ST6GALNAC3 | 1.91e-03 | 451 | 216 | 10 | EFO_0010067 |
| Disease | blood urea nitrogen measurement | CYP1A1 PPARGC1A NFATC3 ARID5B PLCB1 ADGRL2 PRSS23 CPS1 SLC16A3 TANC1 | 1.94e-03 | 452 | 216 | 10 | EFO_0004741 |
| Disease | Prostatic Neoplasms | CYP1A1 HSP90B1 IL16 RPN2 DNMT1 HSP90AB1 FOXO1 CUL3 ITSN1 EI24 IGF2R P4HB | 2.07e-03 | 616 | 216 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP1A1 HSP90B1 IL16 RPN2 DNMT1 HSP90AB1 FOXO1 CUL3 ITSN1 EI24 IGF2R P4HB | 2.07e-03 | 616 | 216 | 12 | C0376358 |
| Disease | cardiovascular disease | TDRD15 HIVEP2 MYO9B ARID5B PLCB1 DLG2 DNMT1 CACNA1D WRN GTF2I | 2.10e-03 | 457 | 216 | 10 | EFO_0000319 |
| Disease | platelet measurement | 2.35e-03 | 315 | 216 | 8 | EFO_0005036 | |
| Disease | gut microbiome measurement, bone density | 2.61e-03 | 78 | 216 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | Prostatic Intraepithelial Neoplasias | 2.81e-03 | 11 | 216 | 2 | C0282612 | |
| Disease | 1-methylxanthine measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0021174 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 2.81e-03 | 11 | 216 | 2 | EFO_0800951 | |
| Disease | Long QT Syndrome | 2.81e-03 | 11 | 216 | 2 | C0023976 | |
| Disease | Unipolar Depression | 3.10e-03 | 259 | 216 | 7 | C0041696 | |
| Disease | Arthritis, Collagen-Induced | 3.13e-03 | 40 | 216 | 3 | C0971858 | |
| Disease | Arthritis, Experimental | 3.13e-03 | 40 | 216 | 3 | C0993582 | |
| Disease | Arthritis, Adjuvant-Induced | 3.13e-03 | 40 | 216 | 3 | C0003865 | |
| Disease | essential tremor | 3.33e-03 | 136 | 216 | 5 | EFO_0003108 | |
| Disease | phenylacetylglutamine measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0021013 | |
| Disease | Dental enamel hypoplasia | 3.35e-03 | 12 | 216 | 2 | EFO_1001304 | |
| Disease | distal myopathy (implicated_via_orthology) | 3.35e-03 | 12 | 216 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma | 3.36e-03 | 41 | 216 | 3 | EFO_0000182 | |
| Disease | Parkinson Disease | 3.56e-03 | 85 | 216 | 4 | C0030567 | |
| Disease | bitter beverage consumption measurement | 3.60e-03 | 42 | 216 | 3 | EFO_0010089 | |
| Disease | apolipoprotein B measurement | TDRD15 ABCA10 ABCB1 ABCB4 AP1G1 EIF2B4 DMWD DNAJC13 A1CF PSD3 BAZ1B IGF2R | 3.74e-03 | 663 | 216 | 12 | EFO_0004615 |
| Disease | phospholipid measurement | 3.76e-03 | 140 | 216 | 5 | EFO_0004639 | |
| Disease | influenza A (H1N1) | 3.87e-03 | 87 | 216 | 4 | EFO_1001488 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.95e-03 | 13 | 216 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 3.95e-03 | 13 | 216 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | cholelithiasis | 4.03e-03 | 88 | 216 | 4 | EFO_0004799 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.11e-03 | 44 | 216 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | vital capacity | CYP1A1 HIVEP2 AK9 ACTN3 RYR2 ARID5B PLCB1 ADGRL2 ZNF438 CUL3 RBBP8 MYH7B NOB1 AFF3 PCDHA11 FOLH1B HSP90AB2P MAPKBP1 | 4.49e-03 | 1236 | 216 | 18 | EFO_0004312 |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 4.58e-03 | 14 | 216 | 2 | C1858991 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 4.58e-03 | 14 | 216 | 2 | EFO_0008212 | |
| Disease | platelet crit | MYO9B IKZF1 KDM6B SLFN14 SH3BP4 ARID5B PLCB1 THEMIS2 FOXO1 RTTN AFF3 RICTOR ZC3H18 CPS1 SYF2 | 4.59e-03 | 952 | 216 | 15 | EFO_0007985 |
| Disease | disorder of pharynx | 4.66e-03 | 46 | 216 | 3 | MONDO_0020592 | |
| Disease | resting heart rate | 4.90e-03 | 149 | 216 | 5 | EFO_0004351 | |
| Disease | hemolysis | 4.95e-03 | 47 | 216 | 3 | EFO_0009473 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 5.26e-03 | 15 | 216 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | 1,3,7-trimethylurate measurement | 5.26e-03 | 15 | 216 | 2 | EFO_0021172 | |
| Disease | Tinnitus, response to cisplatin | 5.26e-03 | 15 | 216 | 2 | GO_0072718, HP_0000360 | |
| Disease | B-cell acute lymphoblastic leukemia | 5.26e-03 | 15 | 216 | 2 | EFO_0000094 | |
| Disease | fat body mass | 5.42e-03 | 217 | 216 | 6 | EFO_0005409 | |
| Disease | Seizures | 5.54e-03 | 218 | 216 | 6 | C0036572 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 5.56e-03 | 49 | 216 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | Intrahepatic cholestasis of pregnancy | 5.98e-03 | 16 | 216 | 2 | EFO_0009048 | |
| Disease | Abnormal behavior | 5.98e-03 | 16 | 216 | 2 | C0233514 | |
| Disease | migraine without aura, susceptibility to, 4 | 5.98e-03 | 16 | 216 | 2 | MONDO_0011847 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 6.09e-03 | 157 | 216 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 ABCB4 DLC1 PLXNA3 DNAJC13 A1CF PNLIPRP2 PSD3 HEATR5A DPP3 ZZZ3 IGF2R | 6.58e-03 | 713 | 216 | 12 | EFO_0005689 |
| Disease | erythrocyte cadmium measurement | 6.75e-03 | 17 | 216 | 2 | EFO_0007807 | |
| Disease | protein C measurement | 6.75e-03 | 17 | 216 | 2 | EFO_0004633 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKLGTKYSDFNASPF | 236 | A8MVM7 | |
| SLKPNYLSQAKTDFS | 1066 | Q68DN1 | |
| SLFSEPYKTNKGDEL | 51 | P51826 | |
| DGSYKPSFLTDQELK | 151 | P27540 | |
| YTFGKEPTLNKVLDA | 371 | Q8NDM7 | |
| VKSKQFSPSGYLSDT | 1606 | O94986 | |
| KALYPGAKEETLASS | 326 | Q5SZB4 | |
| LVESADTPKASKGSY | 511 | P0C7U0 | |
| RLSAGYSPSYDKDKS | 21 | Q96FG2 | |
| FAALSPGELALYKSE | 411 | Q8WWN8 | |
| LYEALKTIPKGFSSS | 521 | Q99708 | |
| PAYFASKDGISKDGS | 61 | O76031 | |
| LEAYNAKSKSFEDPP | 1086 | P26358 | |
| PKLSAFVDEAKTYAA | 501 | Q9NQ94 | |
| TNKFPDLYSDLDKCS | 666 | Q8WWZ4 | |
| PAKPDSSFYKGLDLN | 351 | P02730 | |
| LEKYLKGEDPFTSET | 536 | O43823 | |
| FKLEYSKLLLAPGSS | 286 | Q96NN9 | |
| KSGIYFEPDCSSKNL | 261 | O60911 | |
| FQGYLKDPAKTAEAL | 516 | P33121 | |
| KYSLPSKFSDFLLDP | 281 | Q9UIG0 | |
| FIGDEAIDKPTYATK | 61 | Q9P1U1 | |
| GLSFYADKPETTKEQ | 141 | P19652 | |
| FKPATSKAGNSEVYV | 301 | Q8IYT2 | |
| KIYIPQAFLKDSSGS | 4096 | Q86UQ4 | |
| KPSEKDSAGRSYNKL | 581 | O95490 | |
| PKSLTDSCLFEKSGY | 1481 | Q9UKA4 | |
| SEAGDKASKGPLYSN | 26 | Q8TF44 | |
| EGFSVYAAKSKAPRN | 261 | Q09019 | |
| QEKKSLFYVPKSDGS | 336 | O60312 | |
| NKSTDGAYKPSFLTE | 121 | Q9HBZ2 | |
| GKSKPASDYLNFDSD | 161 | Q9Y4C8 | |
| NQFKSAPSDSLTYKL | 446 | Q15042 | |
| VPSSKVSGKSDYFLI | 26 | P0C0P6 | |
| FSASYKTLPRGTAKE | 266 | Q15113 | |
| PSLNAFKDLNEKFYS | 246 | P04798 | |
| GLDNKCSVYPLTFDK | 166 | O14775 | |
| GPSTAKLDYSKFQEL | 376 | P22736 | |
| VSSFAPDYAKAKISA | 991 | P08183 | |
| ASGIFLAAEKYAPSK | 401 | O43747 | |
| ADFKNKSKGNPYSDL | 786 | Q4KMQ2 | |
| SKSDSDLIAYPSNEK | 736 | Q7Z6G8 | |
| YVKGDLFACPKTDSL | 16 | Q9Y530 | |
| DSNYVSKGSTFLPVK | 846 | P16234 | |
| KGIEYADSFTFNPSK | 291 | P19113 | |
| YSEKTTLFSKGPEDT | 4131 | Q8WXI7 | |
| EYFSLDSPTNGKQIK | 176 | Q9Y5I1 | |
| YESLTDPSKLDSGKE | 56 | P08238 | |
| VTEFSKKTGDYPSLS | 66 | Q9ULX3 | |
| KKTGDYPSLSATDIQ | 71 | Q9ULX3 | |
| GGPYLQFLSTSKSKA | 126 | Q5T9C9 | |
| KPDFKALTDSNAILY | 451 | Q9Y5Z7 | |
| PSKIGAYFSSILAEK | 66 | Q86YW9 | |
| DSIFGDPKKLLTQYF | 236 | P43360 | |
| YSAQFKGEASKPTTA | 336 | Q96JE9 | |
| SYAKDLGVPDTKAAF | 251 | O15427 | |
| YESLTDPSKLDSGKE | 56 | Q58FF8 | |
| YESLTDPSKLDSGKE | 56 | Q58FF7 | |
| LFDKSKTVYEGPFAS | 386 | O15111 | |
| KNPKEAPKSFSFDYS | 41 | O60333 | |
| TKSLTAAFYGDKQPV | 1321 | Q2LD37 | |
| VKGKFRESYLSPAQS | 1151 | O15054 | |
| SKGEESKISYPNIFF | 151 | Q6ICG6 | |
| KGKIEALAFSPNDLY | 111 | Q8N1V2 | |
| LPSFYKIGSKRANFD | 56 | Q86XP3 | |
| TLKDQPSAYSKGFLN | 151 | P43897 | |
| PKASDASFRAKLYDN | 586 | A7E2Y1 | |
| VDGKSEYFPTLSSRK | 171 | P51805 | |
| PYSELAKLSGSFLKE | 91 | P01213 | |
| KSGSPDLSEDQYFVK | 756 | Q9H706 | |
| KTGLKANEPTYFTVD | 776 | Q14315 | |
| VYNLTKELKSPDEGF | 166 | Q9HBA9 | |
| LDTANGTPKVYKSAD | 761 | Q14005 | |
| LCGFSDSKIQKYSPS | 2556 | Q6KC79 | |
| LTTGYDDSQPDKKAV | 521 | Q96G03 | |
| FYNEPIGDAKKSTSA | 856 | P63132 | |
| SYPAKLSFISEGEIK | 281 | Q9UN81 | |
| TSKLKSYEFRGSPFQ | 231 | Q9NY33 | |
| DAAYSIFQKPKSFTG | 226 | Q6YN16 | |
| KGFYTAPDAKLITLA | 541 | O00522 | |
| PAASYRKKDSGVQES | 1436 | P00451 | |
| LPKSVSDYDGKLSNF | 261 | P07237 | |
| KFLGDKGLSDTPYDS | 281 | Q13422 | |
| KGDISTKFLSDVYPD | 496 | P05165 | |
| FKTADDPSLSLIKYG | 76 | P39656 | |
| ASFLDSPGYSKDKPS | 816 | A7KAX9 | |
| KDYGSKVSLFSHLPQ | 171 | Q9UI10 | |
| TFYDRSGPIKDKNSF | 1071 | Q6R327 | |
| FYNEPIGDAKKRAST | 856 | P63135 | |
| FYNEPIRDAKKSTSA | 856 | Q9BXR3 | |
| KIGQKSYDPFASSEK | 146 | Q8NFU5 | |
| KSYQEVSFDPARGLK | 3176 | Q9UPN3 | |
| DTASSPKDQEKYGLL | 456 | Q8IWW6 | |
| SSFAPDYAKAKLSAA | 991 | P21439 | |
| SNNSPEGKKLLSLSY | 251 | Q9H208 | |
| SLSDSDFDKPEKLYS | 91 | Q7Z309 | |
| FDPASTKSKYDSLDF | 771 | Q9UBK2 | |
| PSLSGLKLGFESIYK | 171 | P49643 | |
| TSAPRGLFDEYGSKK | 391 | P14625 | |
| EKSSIFRTPEKGDYN | 481 | Q66GS9 | |
| ASKATGYPLAFIAAK | 726 | P31327 | |
| DAFTSPYINNKLEGK | 561 | Q9C0G6 | |
| VKSVPYFKDKGDSNS | 191 | Q12778 | |
| KEVASSVSFGLFYKP | 266 | P32927 | |
| SKDDSPSYLPTKLAA | 101 | Q86XA9 | |
| NKDDTAAYLPTKLAA | 101 | Q9P2D3 | |
| SLKSDFEYTLGSPKA | 226 | Q8TE85 | |
| AETPRLGKKNESSYF | 506 | P54132 | |
| GRFSPLYKQDSSKLS | 546 | Q5JSL3 | |
| FSKDTYSKPSISGIE | 2036 | O15078 | |
| SADKNGFKARYPAVD | 626 | O00548 | |
| KYQKEEFCGLLSSPT | 3856 | Q9Y6R7 | |
| AKITVSPEGSAKYNF | 46 | Q5T0N1 | |
| LDSSGYFAKKEALVP | 426 | Q6VVX0 | |
| NGYPDFTTRKTLANK | 46 | A0A1W2PPK0 | |
| DDAFAKGPTLTVYKE | 216 | Q13616 | |
| KTVTYLGKFAFDSPS | 81 | Q06889 | |
| SANEAKTPGKAYLFQ | 276 | O14681 | |
| SADLNATFYGPVKKE | 556 | Q13618 | |
| KAGVFPSNYVRLKDS | 1046 | Q15811 | |
| LEDFQHSKGKEPYSS | 181 | P56937 | |
| VPKAFAASLLDYIGS | 1706 | O75165 | |
| DSPQSLSKFYAGLKE | 866 | Q99698 | |
| DFHIPKATLKDSGSY | 156 | O75015 | |
| TSKDKSGAYLFLPDG | 806 | P49641 | |
| KTITALAFSPDGKYL | 91 | O60336 | |
| VNPLFSKYKAGESLE | 6 | P31273 | |
| NAKKYSTFGEAASAP | 126 | P43166 | |
| DYDKSKDSGLPSQGL | 546 | Q15700 | |
| PKDSGEYKAVAENTL | 1221 | Q86VF2 | |
| YESLTDPSKLDSGKE | 61 | P07900 | |
| TFGTKEPLYEKDSSV | 46 | O43809 | |
| DAAFETLSDPKYSGK | 506 | Q5T890 | |
| ALGSTEAKAVPYQKF | 481 | P78347 | |
| SALGFKELGPYSSKT | 56 | P17655 | |
| ETKNSGSDSPYKAKL | 891 | Q9BY12 | |
| LDSLGVKYDSSEPSK | 4136 | Q9NZJ4 | |
| LTSSDTFKEYDPDGK | 4026 | Q92736 | |
| KPSKASDLDDYLGFL | 501 | O75923 | |
| ENLLGSYFPKKISEL | 26 | Q06323 | |
| VAGLDSSKAQKYSPS | 1961 | Q01668 | |
| YESLTDPSKLDSGKE | 61 | Q14568 | |
| TLKGPNDFKLEDFYS | 301 | Q8N1G2 | |
| FDGQSALLYTLDKKP | 186 | Q96NU0 | |
| SKQYEIFKGSLKPDA | 386 | P54317 | |
| ATIKLSKSKDFYPGT | 81 | P51513 | |
| VAKDKASFRNYTSGP | 21 | Q9UGB7 | |
| ISSFILENKGYPSKS | 501 | Q9NXL9 | |
| GASLYDSEPRKKSVN | 51 | Q6ZN04 | |
| FSFDLSPLTKKNGAY | 636 | P11717 | |
| LTYKGPLSAKGTADA | 1021 | P11717 | |
| GKPYLESFKLSLDNT | 796 | Q9NQC3 | |
| EAYSLAKKTFPNSEA | 2191 | Q86VV8 | |
| KTATKKGTAAPYFNE | 296 | Q8NBV8 | |
| GKIYCLSSEEALKPF | 361 | Q5TCS8 | |
| LGSAFELSYDQKKAP | 106 | Q9HCN2 | |
| ETSFQKLLPSGSQKY | 81 | P0C7P3 | |
| KRKNPDLGFSDYAAA | 116 | O95926 | |
| NGTDKTPALISDYKE | 966 | Q02880 | |
| YCPTNFTTLKFSKGD | 66 | Q9P0V3 | |
| KSGKPSVEDQFTRAY | 11 | Q8IZU3 | |
| IIPGSSCLFKYKSED | 1781 | B5MCY1 | |
| KFDAFLKQSLPSYDL | 686 | Q6ZUX3 | |
| GKDFLLNYPFSTSVK | 141 | O95084 | |
| ENTSKGDKLQSPRFY | 446 | Q16819 | |
| LALSQSDPTFGKKSF | 576 | Q86YN6 | |
| LAGFKYNFSDLKSPL | 276 | Q9Y274 | |
| EKYSSPGLTSKESLF | 266 | Q9BPZ7 | |
| AYFGPEASASKFKLL | 261 | Q9UJ37 | |
| LLKNPDYFFKEANTT | 136 | Q8NDV1 | |
| DTNNFPYLEKTAKKG | 136 | Q9NR45 | |
| KPDYGDTLSSFITKI | 601 | Q9C0D5 | |
| LFALYPKTNKDGFRS | 1111 | Q9UL54 | |
| FGKTYDAPSALPKAT | 46 | Q9NZH5 | |
| SKFPLTEDQKLYAAT | 201 | Q14191 | |
| SLLCKFSPDGKYLAS | 11 | Q9P2S5 | |
| EAGKKALADAQIPYS | 41 | P22307 | |
| ALLEKYTPSNKHGFS | 1041 | Q96QB1 | |
| NKVPGLYKSSSADSL | 736 | Q9UQ84 | |
| YANPSAKEKASLTKG | 256 | Q9NZP0 | |
| KKYLKEAPLASSANG | 211 | Q9BSK2 | |
| GASSGKPTEKNLYAD | 131 | Q5VST6 | |
| KYSSDEDLPSKLEGF | 36 | P55008 | |
| SFKILAGDKNYITPE | 841 | Q08043 | |
| KIEGYQEFSAKPLAS | 496 | Q14865 | |
| SGYDNIFKTPKELSC | 56 | E7ERA6 | |
| AVGYQASKPDALSKL | 46 | Q8N8J6 | |
| GAPLKEFAIKESTYT | 141 | Q8WYP3 | |
| SYSKDGAKSLKGDVP | 101 | Q9HCE3 | |
| LGKNFDSAKVPSDEY | 31 | Q5W0Q7 | |
| SPAEDKSSFKPYSKG | 146 | Q9H7S9 | |
| SAFLRPKLGKQYEAS | 31 | Q8N2C7 | |
| TFGSAGSINYPDKKA | 916 | O43295 | |
| YPEEFSLLKLQTKDG | 126 | Q496A3 | |
| VTYPAKAKGTFIADS | 396 | P04844 | |
| AKTLPEFIKDGSSTY | 591 | Q5TEJ8 | |
| EFIKDGSSTYSKIPA | 596 | Q5TEJ8 | |
| ALIKDFQGTPTFTYK | 86 | Q15833 | |
| FYNEPIGDAKKRAST | 856 | P10266 | |
| DKLVLSTAQKPGDSY | 246 | Q8NEB5 | |
| FYNEPIRDAKKSTSA | 856 | P63133 | |
| YSGPSLSDKEKLNVE | 551 | P80108 | |
| FYKFCSLPEKGTLTE | 706 | P29144 | |
| EFGFDKYSSKPDILN | 546 | Q6UXI7 | |
| YPLKKDSCGDQFLSV | 381 | Q12968 | |
| FYNEPIGDAKKRAST | 856 | Q9UQG0 | |
| SGDGYAKDAKLSAPS | 1461 | Q9P273 | |
| TPEEKDKLFTAIGYS | 501 | Q709C8 | |
| LKNESSDYTKPGDID | 241 | Q9UBS9 | |
| TSQFDGDYISKLPKS | 1036 | Q9UBS9 | |
| DNIFSEFGAKSKPYL | 226 | Q9NQ66 | |
| AVGYQASKPDALFKL | 46 | Q9GZX5 | |
| RKSLSALAFSPDGKY | 111 | O43379 | |
| SSYALGSNAEDKPIK | 111 | Q8WV37 | |
| ASYLIAFQTAASKKP | 831 | O95789 | |
| SVGYQASKPDALFKL | 46 | Q6PF04 | |
| SSGEIKDFSPKNVIY | 81 | P52738 | |
| DFSLKSNRQKTPYEG | 311 | Q5JVG2 | |
| GAYFDKAKEKSPIQS | 1666 | Q01118 | |
| KPFEYGKSFNRNSTL | 311 | Q6ZMW2 | |
| ASGESFSKDPYVLSK | 2266 | P31629 | |
| KPIKDQLGSSFYSHL | 81 | Q6ZNG1 | |
| PLKYIEGDKAFNQSS | 181 | Q96H40 | |
| PKIVNLGSSKTDLFY | 86 | Q7RTV0 | |
| LASEASDKGNLPKYS | 656 | Q9Y4E6 | |
| YKIKSDANIAGFSLP | 306 | Q7Z4V0 | |
| SPLDPKKDGESLSYS | 606 | Q8IYH5 | |
| DPNAAVYKSGFLARK | 781 | Q9NYI0 | |
| KFSPNGKYILAATLD | 221 | P61964 | |
| FNPSGSKDGKYELLT | 91 | Q13889 | |
| NDKGNYSLITKADPF | 246 | Q86VM9 | |
| KSPASDTYIVFGEAK | 1976 | E9PAV3 | |
| ELLYSSKQSFPGILK | 1241 | Q86UW6 | |
| KLGFSSPYEGVLNKS | 1921 | Q13459 | |
| AFYSPGLQAKKDLES | 1426 | Q5VU43 | |
| ETFNKAKGKYTFSPD | 4426 | P20929 | |
| YDTPDFTLAEKNKTL | 5351 | P20929 |